Role of renin-angiotensin system in prostate cancer

Japanese Journal of Cancer and Chemotherapy

Volumn 36, Issue 8, 2009, Pages 1228-1233

  Uemura, Hiroji ^a   Kubota, Yoshinobu ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II receptor blocker; Hormone refractory cancer; Prostate cancer; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; PROSTATE SPECIFIC ANTIGEN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; DRUG TARGETING; HUMAN; MITOGENESIS; OXIDATIVE STRESS; PILOT STUDY; PROSTATE CANCER; PROSTATECTOMY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 79959848658     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Huggins C and Hodges CV: Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin 22: 232-240, 1972.
2. Lever AF, Hole DJ, Gillis CR, et al: Do inhibitors of angiotensin- I -converting enzyme protect against risk of cancer ? Lancet 352: 179-184, 1998.
3. van der Knaap R, Siemes C, Coebergh JW, et al: Renin-angiotensin system inhibitors, angiotensin I -converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer 112: 748-757, 2008. (Pubitemid 351240568)
4. Egami K, Murohara T, Shimada T, et al: Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112: 67-75, 2003. (Pubitemid 38056377)
5. Fujimoto Y, Sasaki T, Tsuchida A, et al: Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 495: 197-200, 2001. (Pubitemid 32397704)
6. Muscella A, Greco S, Elia MG, et al: Angiotensin II stimulation of Na+/K+ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. J Endocrinol 173: 315-323, 2002. (Pubitemid 34552460)
7. Rivera E, Arrieta O, Guevara P, et al: AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. Br J Cancer 85: 1396-1399, 2001. (Pubitemid 33081938)
8. Leung PS and Sernia C: The renin-angiotensin system and male reproduction: new functions for old hormones. J Mol Endocrinol 30: 263-270, 2003. (Pubitemid 36722617)
9. O'Mahony OA, Djahanbahkch O, Mahmood T, et al: Angiotensin II in human seminal fluid. Hum Reprod 15: 1345-1349, 2000.
10. Dinh DT, Frauman AG, Somers GR, et al: Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT (1) receptor expression in benign prostatic hyperplasia. J Pathol 196: 213-219, 2002. (Pubitemid 34110903)
11. O'Mahony OA, Barker S, Puddefoot JR, et al: Synthesis and secretion of angiotensin II by the prostate gland in vitro. Endocrinology 146: 392-398, 2005. (Pubitemid 40051763)
12. Naruse K, Murakoshi M, Osamura RY, et al: Immunohistological evidence for renin in human endocrine tissues. J Clin Endocrinol Metab 61: 172-177, 1985. (Pubitemid 15046212)
13. Nassis L, Frauman AG, Ohishi M, et al: Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia. J Pathol 195: 571-579, 2001. (Pubitemid 34030795)
14. van Sande ME, Scharpe SL, Neels HM, et al: Distribution of angiotensin converting enzyme in human tissues. Clin Chim Acta 147: 255-260, 1985. (Pubitemid 15083894)
15. Yokoyama M, Hiwada K, Kokubu T, et al: Angiotensinconverting enzyme in human prostate. Clin Chim Acta 100: 253-258, 1980. (Pubitemid 10166706)
16. Uemura H, Hasumi H, Kawahara T, et al: Pilot study of angiotensin II receptor blocker in advanced hormonerefractory prostate cancer. Int J Clin Oncol 10: 405-410, 2005.
17. Yigit B, Bozkurt N, Narter F, et al: Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis. Anticancer Res 27: 933-936, 2007. (Pubitemid 46587002)
18. Uemura H, Ishiguro H, Nakaigawa N, et al: Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther 2: 1139-1147, 2003.
19. Chow L, Rezmann L, Imamura K, et al: Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines. Prostate 68: 651-660, 2008. (Pubitemid 351614643)
20. Dinh DT, Frauman AG, Sourial M, et al: Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia. Endocrinology 142: 1349-1356, 2001. (Pubitemid 32202848)
21. Fabiani ME, Hawkes DJ, Frauman AG, et al: Regulation of angiotensin II receptors in the prostate of the transgenic (mRen-2) 27 rat: effect of angiotensin-converting enzyme inhibition. Int J Biochem Cell Biol 35: 973-983, 2003. (Pubitemid 36379336)
22. Peng H, Moffett J, Myers J, et al: Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol Biol Cell 12: 449-462, 2001.
23. Dinh DT, Frauman AG, Casley DJ, et al: Angiotensin AT (4) receptors in the normal human prostate and benign prostatic hyperplasia. Mol Cell Endocrinol 184: 187-192, 2001.
24. Wright JW and Harding JW: The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Prog Neurobiol 72: 263-293, 2004. (Pubitemid 38609580)
25. Uemura H, Hasumi H, Ishiguro H, et al: Renin-angiotensin system is an important factor in hormone refractory prostate cancer. Prostate 66: 822-830, 2006.
26. Louis SN, Wang L, Chow L, et al: Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate. Cancer Detect Prev 31: 391-395, 2007. (Pubitemid 350166787)
27. Kosaka T, Miyajima A, Takayama E, et al: Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer. Prostate 67: 41-49, 2007. (Pubitemid 46013466)
28. Uemura H, Ishiguro H and Kubota Y: Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment. Int J Urol 15: 19-26, 2008.
29. Uemura H, Ishiguro H, Nagashima Y, et al: Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Mol Cancer Ther 4: 1699-1709, 2005. (Pubitemid 41685304)
30. Teranishi JI, Ishiguro H, Hoshino K, et al: Evaluation of role of angiotensin III and aminopeptidases in prostate cancer cells. Prostate 68: 1666-1673, 2008.
31. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002. (Pubitemid 36019639)
32. Uemura H, Ishiguro H, Ishiguro Y, et al: Angiotensin II induces oxidative stress in prostate cancer. Mol Cancer Res 6: 250-258, 2008. (Pubitemid 351342413)